Prolonged interferon-gamma exposure decreases ion transport, NKCC1, and Na+-K+-ATPase expression in human intestinal xenografts in vivo.
about
K+ Channel Inhibition Differentially Regulates Migration of Intestinal Epithelial Cells in Inflamed vs. Non-Inflamed Conditions in a PI3K/Akt-Mediated MannerGiardia duodenalis infection reduces granulocyte infiltration in an in vivo model of bacterial toxin-induced colitis and attenuates inflammation in human intestinal tissueChanges in ion transport in inflammatory diseaseLoss of protein tyrosine phosphatase N2 potentiates epidermal growth factor suppression of intestinal epithelial chloride secretion.Cytokine regulation of OCTN2 expression and activity in small and large intestineClcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis.Cholinergic regulation of epithelial ion transport in the mammalian intestineDownregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrheaMolecular bases of impaired water and ion movements in inflammatory bowel diseases.AMP-activated protein kinase mediates the interferon-gamma-induced decrease in intestinal epithelial barrier function.Intestinal inflammation and the enterocyte transportome.The application of Ussing chambers for determining the impact of microbes and probiotics on intestinal ion transport.Epithelial transport in inflammatory bowel diseases.Role of epithelial ion transports in inflammatory bowel disease.Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction.Loss of Ca-mediated ion transport during colitis correlates with reduced ion transport responses to a Ca-activated K channel opener.Dynamic and differential regulation of NKCC1 by calcium and cAMP in the native human colonic epithelium.
P2860
Q27324841-363C74B3-3B50-4DE6-AB8C-5769DEAFAC0CQ27342150-83DB0A70-25AC-4705-87EB-DBA05386744BQ28196218-28310C50-EA95-4274-8FB8-B1568442A707Q34212116-7D5FD5AF-04E6-4F85-B2AA-058609154001Q34345020-4072C823-FC8D-4107-BA43-10961860451FQ35702593-F2C7CA17-1AA4-4536-B51F-B908912D1831Q36596497-2C2E8F30-2CB9-4300-8575-E667969D9A28Q37064596-21492D1A-3C8C-4B89-A9ED-C4C2CF49B341Q37216498-E0816B78-0E1A-4EF6-A634-15DD9758B8FCQ37459893-520A67C3-0370-4F25-8B84-7FDE0FE16345Q37905164-17CE38A8-786A-43DF-9158-35160BDC65D4Q38132251-682281A3-94E8-4869-9F8A-9857601795B7Q38201235-2707546F-09BA-47DD-8521-4A76B4186B80Q38690199-C5EA978E-A888-480C-83E0-DEF3B8A9F1D2Q38931622-20B94118-FF05-4266-B663-F065EAFA73AAQ41429236-E09523A1-2F82-4759-8871-E543E430F321Q41943073-9BC68E35-64EC-4CC1-9DB0-359D49F87310
P2860
Prolonged interferon-gamma exposure decreases ion transport, NKCC1, and Na+-K+-ATPase expression in human intestinal xenografts in vivo.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Prolonged interferon-gamma exp ...... intestinal xenografts in vivo.
@en
Prolonged interferon-gamma exp ...... intestinal xenografts in vivo.
@nl
type
label
Prolonged interferon-gamma exp ...... intestinal xenografts in vivo.
@en
Prolonged interferon-gamma exp ...... intestinal xenografts in vivo.
@nl
prefLabel
Prolonged interferon-gamma exp ...... intestinal xenografts in vivo.
@en
Prolonged interferon-gamma exp ...... intestinal xenografts in vivo.
@nl
P2093
P2860
P356
P1476
Prolonged interferon-gamma exp ...... intestinal xenografts in vivo.
@en
P2093
Kim E Barrett
Lars Eckmann
Lone S Bertelsen
P2860
P304
P356
10.1152/AJPGI.00227.2003
P577
2003-09-04T00:00:00Z